Orris
attachment

Clinical Question 6B AMONG INFANTS AND CHILDREN AGED 3 MONTHS TO 18 YEARS WITH BACTERIAL COMMUNITY- ACQUIRED PNEUMONIA, WILL THE ADDITION OF A MACROLIDE TO STANDARD EMPIRIC REGIMEN IMPROVE TREATMENT OUTCOME? Give me a content for the question to the ppt making for a 2 slides from above given picture

Reading File
Reading File
Running Command
Running Command
Writing File
Running Command
Your 2-slide presentation is ready:

ClinicalQuestion6B Macrolide PCAP

Presentation · PPTX

Here's what's on each slide:
Slide 1 — Clinical Question + Key Recommendation
  • CPG 2021 badge + "Clinical Question 6B" label in the teal header
  • Full question title: Macrolide Addition to Standard Empiric Regimen in Pediatric Bacterial CAP
  • Authors (Alvarado-Dela Cruz & Dela Cruz)
  • Population strip: Infants and children aged 3 months – 18 years with bacterial PCAP
  • Key Recommendation card (rose-bordered):
    • "The addition of a macrolide to standard beta-lactam antibiotic therapy is NOT recommended in the empiric treatment of bacterial PCAP."
    • Grade badge: Conditional Recommendation | Very Low-Grade Evidence
Slide 2 — Summary of Evidence (3 Outcomes)
  • Outcome 1 – Macrolide Resistance (CRITICAL importance, red banner)
    • 24 studies, meta-analysis of RCTs (Chen et al., 2020) → Pooled OR 4.42 (95% CI 2.32–8.41) — High grade
  • Outcome 2 – Length of Hospitalization (NOT CRITICAL, green banner)
    • 9 studies, meta-analysis of cohort/case-control → LOS difference −0.051 days, p=0.756; HR 0.92 — Very Low grade
  • Outcome 3 – Treatment Failure (NOT CRITICAL, yellow banner)
    • 1 cohort study (Ambroggio et al., 2016) → 14-day & 7-day TF ORs by age group — Very Low grade
Design uses a dark navy background with teal headers, rose/green/yellow outcome banners, and gold data-table headers for clean readability.
This is a shared conversation. Sign in to Orris to start your own chat.